Skip to content
AI.info

The Pulse

Concentrate AI launches healthcare gateway with $499 monthly BAA

Concentrate AI has launched a healthcare gateway offering access to eligible AI models through one API and business associate agreement. Healthcare access costs $499 per month, with inference billed at provider rates.

Concentrate AI launches healthcare gateway with $499 monthly BAA

Healthcare and life sciences companies can access eligible AI models through a single API and business associate agreement under a new gateway from Concentrate AI. The company announced the offering on November 12, with healthcare access priced at $499 per month and inference billed at provider rates, without token markups or annual inference spending commitments.

The gateway supports eligible models including OpenAI’s GPT, Anthropic’s Claude and Google’s Gemini through Vertex AI, as well as open-weight alternatives. Model coverage is limited to supported inference routes and configurations.

One agreement for covered routes

The offering is open to organizations handling protected health information or personally identifiable information, including those outside healthcare. Concentrate manages agreements and access to covered inference services from participating providers, so customers do not need to negotiate separate contracts with each provider for supported models.

Customers can also use existing provider credentials and credits through a bring-your-own-key arrangement where supported. The team using the gateway still selects its model, validates responses and sets permitted fallback destinations.

In a separate post about using DeepSeek through the gateway, Concentrate says protected health information requires a signed business associate agreement, a HIPAA-enabled gateway organization and routing restricted to eligible providers. The company says those conditions do not replace the customer’s own HIPAA obligations.

Costs and controls

Concentrate says switching to lower-cost open-weight models for suitable workloads can reduce inference costs by up to 70%, depending on performance and latency requirements. The monthly healthcare charge is separate from inference, which is billed at provider rates.

The platform provides managed large language model operations, including spend management, observability and enterprise governance. Its security features include role-based access controls, single sign-on, supported zero-data-retention endpoints and multi-cloud resiliency; the platform is backed by a SOC 2 Type II report.

In a post about healthcare inference, the company says automated redaction can reduce exposure but does not guarantee that all protected health information has been removed. It also says fallback destinations for healthcare traffic must be restricted to approved routes.

Healthcare customers

The healthcare launch followed conversations with more than 70 healthcare and life sciences companies, according to the announcement. Concentrate says it is working with more than a dozen healthcare companies, including Kinstead and Hummingbird Healthcare.

Kinstead develops technology to help nurse practitioners launch and manage independent practices. Hummingbird Healthcare, which helps health systems using Epic improve patient access through technology and managed services.

Nick Catalano, Kinstead’s chief technology officer, said that the compliance and operational work of onboarding AI providers had previously discouraged the company from trying new models. He said Kinstead can now evaluate and deploy models without managing separate vendor relationships and integrations.

Since its platform launched in June 2026, Concentrate says it has processed hundreds of millions of requests and trillions of tokens. The company lists Brilliant, Nextiva, Pocket, Proximal and Tiger Data among its platform customers.

Sources

Related stories

Explore

More articles